# A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

Source: https://onco.cc/trials/nct06915246/  
OnCo record `nct06915246` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Carmustine in hodgkin lymphoma and non-hodgkin lymphoma, run by VIVUS LLC, now recruiting.

## Summary

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma is a phase 2 interventional study registered as NCT06915246 by VIVUS LLC, with 49 participants planned, started 2025-03-12 and due to reach its primary completion in 2027-03-31. Interventions recorded: VI-0609, BiCNU. Conditions listed: Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: ctgov-ingest
- Registry id: NCT06915246
- Phase: 2
- Setting: A Randomized Phase 2 Study of Carmustine Formulated With and Without Ethanol as Part of BEAM Chemotherapy Conditioning for Subjects With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation (AHCT)
- Sponsor: VIVUS LLC
- Enrolled: 49

## Sources

- ClinicalTrials.gov NCT06915246: https://clinicaltrials.gov/study/NCT06915246

## Connected records

- cancers: [Hodgkin lymphoma](https://onco.cc/cancers/hodgkin-lymphoma/), [Non-Hodgkin lymphoma (all types)](https://onco.cc/cancers/non-hodgkin-lymphoma/)
- drugs: [Carmustine](https://onco.cc/drugs/carmustine/)

---
JSON: https://onco.cc/api/v1/entities/nct06915246.json